AAAAAA
Results: 1-25/29
Authors:
Takahashi, S
Rousseau, RF
Yotnda, P
Mei, ZY
Dotti, G
Rill, D
Hurwitz, R
Marini, F
Andreeff, M
Brenner, MK
Citation: S. Takahashi et al., Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes, HUM GENE TH, 12(6), 2001, pp. 659-670
Authors:
Brenner, MK
Citation: Mk. Brenner, Gene transfer and the treatment of haematological malignancy, J INTERN M, 249(4), 2001, pp. 345-358
Authors:
Takahashi, S
Yotnda, P
Roosseau, RF
Mei, ZY
Smith, S
Rill, D
Younes, A
Brenner, MK
Citation: S. Takahashi et al., Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma, CANC GENE T, 8(5), 2001, pp. 378-387
Authors:
Bollard, CM
Heslop, HE
Brenner, MK
Citation: Cm. Bollard et al., Gene-marking studies of hematopoietic cells, INT J HEMAT, 73(1), 2001, pp. 14-22
Authors:
Rousseau, RF
Hirschmann-Jax, C
Takahashi, S
Brenner, MK
Citation: Rf. Rousseau et al., Cancer vaccines, HEMAT ONCOL, 15(4), 2001, pp. 741
Authors:
Savoldo, B
Goss, J
Liu, ZS
Huls, MH
Doster, S
Gee, AP
Brenner, MK
Heslop, HE
Rooney, CM
Citation: B. Savoldo et al., Generation of autologous Epstein-Barr virus-specific cytotoxic T cells foradoptive immunotherapy in solid organ transplant recipients, TRANSPLANT, 72(6), 2001, pp. 1078-1086
Authors:
Rossig, C
Bollard, CM
Nuchtern, JG
Merchant, DA
Brenner, MK
Citation: C. Rossig et al., Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes, INT J CANC, 94(2), 2001, pp. 228-236
Authors:
Gahn, B
Siller-Lopez, F
Pirooz, AD
Yvon, E
Gottschalk, S
Longnecker, R
Brenner, MK
Heslop, HE
Aguilar-Cordova, E
Rooney, CM
Citation: B. Gahn et al., Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma, INT J CANC, 93(5), 2001, pp. 706-713
Authors:
Wulf, GG
Wang, RY
Kuehnle, I
Weidner, D
Marini, F
Brenner, MK
Andreeff, M
Goodell, MA
Citation: Gg. Wulf et al., A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia, BLOOD, 98(4), 2001, pp. 1166-1173
Authors:
Horwitz, EM
Prockop, DJ
Gordon, PL
Koo, WWK
Fitzpatrick, LA
Neel, MD
McCarville, ME
Orchard, PJ
Pyeritz, RE
Brenner, MK
Citation: Em. Horwitz et al., Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta, BLOOD, 97(5), 2001, pp. 1227-1231
Authors:
Gottschalk, S
Ng, CYC
Perez, M
Smith, CA
Sample, C
Brenner, MK
Heslop, HE
Rooney, CM
Citation: S. Gottschalk et al., An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs, BLOOD, 97(4), 2001, pp. 835-843
Authors:
Schroers, R
Sinha, I
Segall, H
Schmidt-Wolf, IGH
Rooney, CM
Brenner, MK
Sutton, RE
Chen, SY
Citation: R. Schroers et al., Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system, MOL THER, 1(2), 2000, pp. 171-179
Authors:
Brenner, MK
Citation: Mk. Brenner, Current and future uses for genetic modification of hematopoietic stem cells, EUR CYTOKIN, 11(2), 2000, pp. 321-322
Authors:
Brenner, MK
Heslop, H
Krance, R
Horowitz, M
Strother, D
Nuchtern, J
Grilley, B
Martingano, E
Cooper, K
Citation: Mk. Brenner et al., Clinical protocol - Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector, HUM GENE TH, 11(10), 2000, pp. 1477-1488
Authors:
Rossig, C
Nuchtern, JG
Brenner, MK
Citation: C. Rossig et al., Selection of human antitumor single-chain Fv antibodies from the B-cell repertoire of patients immunized against autologous neuroblastoma, MED PED ONC, 35(6), 2000, pp. 692-695
Authors:
Kuehnie, I
Huls, MH
Liu, ZS
Semmelmann, M
Krance, RA
Brenner, MK
Rooney, CM
Heslop, HE
Citation: I. Kuehnie et al., CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation, BLOOD, 95(4), 2000, pp. 1502-1505
Authors:
Moriwaki, K
Sutton, RE
Perez, M
Brenner, MK
Heslop, HE
Citation: K. Moriwaki et al., Transduction of CD34(+) and CD34(-)/lin(-) hemopoietic progenitors by lentivirus vectors, CYTOTHERAPY, 1(6), 1999, pp. 433-438
Authors:
Brenner, MK
Citation: Mk. Brenner, Fifth Annual ISHAGE Meeting - Oslo 1999, CYTOTHERAPY, 1(3), 1999, pp. 163-163
Authors:
Horwitz, EM
Prockop, DJ
Fitzpatrick, LA
Koo, WWK
Marx, JC
Brenner, MK
Citation: Em. Horwitz et al., Osteogenesis imperfecta calls for caution - Reply, NAT MED, 5(5), 1999, pp. 466-467
Authors:
Horwitz, EM
Prockop, DJ
Fitzpatrick, LA
Koo, WWK
Gordon, PL
Neel, M
Sussman, M
Orchard, P
Marx, JC
Pyeritz, RE
Brenner, MK
Citation: Em. Horwitz et al., Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta, NAT MED, 5(3), 1999, pp. 309-313
Authors:
Brenner, MK
Citation: Mk. Brenner, "Resistance is futile", GENE THER, 6(10), 1999, pp. 1646-1647
Authors:
Heslop, HE
Perez, M
Benaim, E
Rochester, R
Brenner, MK
Rooney, CM
Citation: He. Heslop et al., Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant, J CLIN APH, 14(3), 1999, pp. 154-156
Authors:
Hale, GA
Heslop, HE
Bowman, LC
Rochester, RA
Pui, CH
Brenner, MK
Krance, RA
Citation: Ga. Hale et al., Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies, BONE MAR TR, 24(7), 1999, pp. 735-739
Authors:
Roskrow, MA
Dilloo, D
Suzuki, N
Zhong, WY
Rooney, CM
Brenner, MK
Citation: Ma. Roskrow et al., Autoimmune disease induced by dendritic cell immunization against leukemia, LEUK RES, 23(6), 1999, pp. 549-557
Authors:
Brenner, MK
Pinkel, D
Citation: Mk. Brenner et D. Pinkel, Cure of leukemia, SEM HEMATOL, 36(4), 1999, pp. 73-83